Shailesh B. Lad , Soumyadeep Mandal , Kiran Kondabagil
{"title":"The evolutionary landscape of modern-day replicases and archaeo-eukaryotic primases may have giant viral interventions","authors":"Shailesh B. Lad , Soumyadeep Mandal , Kiran Kondabagil","doi":"10.1016/j.virol.2025.110524","DOIUrl":null,"url":null,"abstract":"<div><div>The viruses from the phylum <em>Nucleocytoviricota</em> have been a central part of the investigation to understand the evolution of viruses because of their atypically large particle size and large DNA genome encoding ORFs for protein translation, metabolism, and DNA replication and repair. <em>Acanthamoeba polyphaga</em> mimivirus (APMV), the founding member of the phylum, encodes a DNA-repair multifunctional PrimPol enzyme belonging to the archaeo-eukaryotic primase (AEP) superfamily. AEPs are enzymes present in all domains of life forms and viruses, and their versatile nature has been hypothesized to have aided in genomic replication and repair during evolution. The broad substrate specificity of AEPs allows them to act as primase, polymerase, and translesion synthesis polymerase (TLS). This multi-operational mode makes them a potential candidate for a primordial enzyme that could have been a part of the still inefficient ancient replication machinery. In this article, using the available sequence, biochemical, and structural information of AEPs, we explore the potential origins of modern-day replicases. In this context, we propose that AEPs, specifically PrimPols, have been central to the inception of modern-day replication machinery. Using APMV PrimPol as a representative candidate, we propose a model in which the parallel evolution of naked DNA elements, early viruses, cellular organisms, and the replication machinery might have occurred.</div></div>","PeriodicalId":23666,"journal":{"name":"Virology","volume":"607 ","pages":"Article 110524"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042682225001370","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The viruses from the phylum Nucleocytoviricota have been a central part of the investigation to understand the evolution of viruses because of their atypically large particle size and large DNA genome encoding ORFs for protein translation, metabolism, and DNA replication and repair. Acanthamoeba polyphaga mimivirus (APMV), the founding member of the phylum, encodes a DNA-repair multifunctional PrimPol enzyme belonging to the archaeo-eukaryotic primase (AEP) superfamily. AEPs are enzymes present in all domains of life forms and viruses, and their versatile nature has been hypothesized to have aided in genomic replication and repair during evolution. The broad substrate specificity of AEPs allows them to act as primase, polymerase, and translesion synthesis polymerase (TLS). This multi-operational mode makes them a potential candidate for a primordial enzyme that could have been a part of the still inefficient ancient replication machinery. In this article, using the available sequence, biochemical, and structural information of AEPs, we explore the potential origins of modern-day replicases. In this context, we propose that AEPs, specifically PrimPols, have been central to the inception of modern-day replication machinery. Using APMV PrimPol as a representative candidate, we propose a model in which the parallel evolution of naked DNA elements, early viruses, cellular organisms, and the replication machinery might have occurred.
期刊介绍:
Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinologists and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work.Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.